Solara Active Pharma Sciences Ltd. - Research Center
541540 SOLARA Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
777.55 |
668.44 |
461.16 |
807.18 |
745.98 |
Operating profit |
56.81 |
37.20 |
-83.68 |
164.03 |
180.63 |
Interest |
49.98 |
44.46 |
39.28 |
35.99 |
39.20 |
Gross profit |
10.13 |
2.99 |
-113.51 |
137.35 |
151.69 |
EPS (Rs) |
-9.76 |
-8.08 |
-38.71 |
22.49 |
27.38 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
3.30 |
10.25 |
9.45 |
9.31 |
10.26 |
Stock adjustment |
-19.69 |
16.73 |
-111.35 |
-147.40 |
5.57 |
Raw material |
444.51 |
365.55 |
385.60 |
473.26 |
301.14 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
125.27 |
109.58 |
108.78 |
125.42 |
111.75 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
170.65 |
139.38 |
161.81 |
191.87 |
146.89 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
51.97 |
56.61 |
56.11 |
55.90 |
53.66 |
Taxation |
-10.25 |
-24.53 |
-33.10 |
- |
- |
Net profit / loss |
-35.14 |
-29.09 |
-139.35 |
80.79 |
98.03 |
Extra ordinary item |
-3.55 |
- |
-2.83 |
-0.66 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
36.00 |
36.00 |
36.00 |
35.93 |
35.81 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
7.31 |
5.57 |
-18.15 |
20.32 |
24.21 |
GPM (%) |
1.30 |
.44 |
-24.12 |
16.82 |
20.06 |
NPM (%) |
-4.50 |
-4.29 |
-29.61 |
9.89 |
12.96 |